<< Read Full Article
<< Read Full Article
Updated from 2:25 p.m. EDT
An advisory panel of the Food and Drug Administration voted to recommend market clearance for Pargluva as a standalone treatment for diabetes. The drug was codeveloped by Bristol-Myers Squibb(BMY Quote) and Merck(MRK Quote).
Despite concerns about the drug's effect on the heart, members of the FDA's Endocrincal and Metabolic Drugs Advisory Committee voted 8-1 to recommend approval of Pargluva as a way to control blood sugar in diabetics, Bloomberg said.
The disease afflicts about 18 million Americans. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,285.97 | 1,091.93 | 2,172.99 | 33.92 |
Oil *
75.40
|
|
DOWN
104.14
|
DOWN
11.32
|
DOWN
16.62
|
DOWN
0.56
|
10 Yr
3.39%
SPDR Gold
110.95
|
|
-1.00%
|
-1.03%
|
-0.76%
|
-1.62%
|
Data delayed 20 minutes |
Connect with TheStreet